Losigamone

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLosigamone
Drug Alias Namelosigamone氯西加酮losigamonumlosigamonaAO-33 +[6] 
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSeizures
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDr. Willmar Schwabe Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchwabe
Active IndicationsN/A
Inactive IndicationsSeizures

Other Information

ATC CodeN/A
Related LinksWikipedia